v3.26.1
Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Series A-2 Prime Preferred Stock
Series B-2 Preferred Stock
Series A-3 Preferred Stock
Additional Paid-In Capital
Accumulated Deficit
Comprehensive Loss
Total
Balance at Dec. 31, 2024 $ 11 $ 108,690 $ (101,270)   $ 7,431
Balance (in Shares) at Dec. 31, 2024 11,384,236 6,150.21 3,000        
Net Income (Loss)   570   570
Conversion of Series A-2 Prime preferred stock into common stock    
Conversion of Series A-2 Prime preferred stock into common stock (in Shares) 140,000 (686)            
Issuance of common stock for cash, net of issuance costs $ 1   2,706   2,707
Issuance of common stock for cash, net of issuance costs (in Shares) 450,738              
Stock-based compensation expense   563   563
Balance at Mar. 31, 2025 $ 12 111,959 (100,700)   11,271
Balance (in Shares) at Mar. 31, 2025 11,974,974 5,464.21 3,000        
Balance at Dec. 31, 2024 $ 11 108,690 (101,270)   7,431
Balance (in Shares) at Dec. 31, 2024 11,384,236 6,150.21 3,000        
Net Income (Loss)               (5,877)
Balance at Jun. 30, 2025 $ 14 123,562 (107,147)   16,429
Balance (in Shares) at Jun. 30, 2025 14,111,852 5,464.21        
Balance at Mar. 31, 2025 $ 12 111,959 (100,700)   11,271
Balance (in Shares) at Mar. 31, 2025 11,974,974 5,464.21 3,000        
Net Income (Loss)     (6,447)   (6,447)
Issuance of Series A-3 preferred stock upon exercise of warrants 1,496   1,496
Issuance of Series A-3 preferred stock upon exercise of warrants (in shares) 1,495.8        
Conversion of Series B-2 preferred stock into common stock  
Conversion of Series B-2 preferred stock into common stock (in shares) 300,000        
Conversion of Series A-3 preferred stock into common stock  
Conversion of Series A-3 preferred stock into common stock (in shares) 277,000 (1,495.8)        
Issuance of common stock for vested restricted stock units  
Issuance of common stock for vested restricted stock units (in shares) 1,000        
Issuance of common stock for cash, net of issuance costs $ 2 9,536   9,538
Issuance of common stock for cash, net of issuance costs (in Shares) 1,558,878              
Stock-based compensation expense 571   571
Balance at Jun. 30, 2025 $ 14 123,562 (107,147)   16,429
Balance (in Shares) at Jun. 30, 2025 14,111,852 5,464.21        
Balance at Dec. 31, 2025 $ 22     158,001 (127,825) $ (1) 30,197
Balance (in Shares) at Dec. 31, 2025 22,114,245 2,265            
Net Income (Loss)     (12,823)   (12,823)
Issuance of common stock for cash, net of issuance costs $ 3     19,566 19,569
Issuance of common stock for cash, net of issuance costs (in Shares) 3,123,537              
Unrealized loss on marketable securities, net     (29) (29)
Stock-based compensation expense     754 754
Balance at Mar. 31, 2026 $ 25     178,321 (140,648) 6 37,704
Balance (in Shares) at Mar. 31, 2026 25,237,782 2,265            
Balance at Dec. 31, 2025 $ 22     158,001 (127,825) (1) 30,197
Balance (in Shares) at Dec. 31, 2025 22,114,245 2,265            
Net Income (Loss)               (14,545)
Balance at Jun. 30, 2026 $ 28     195,635 (142,370) (23) 53,270
Balance (in Shares) at Jun. 30, 2026 27,855,257            
Balance at Mar. 31, 2026 $ 25     178,321 (140,648) 6 37,704
Balance (in Shares) at Mar. 31, 2026 25,237,782 2,265            
Net Income (Loss)     (1,722) (1,722)
Conversion of Series A-2 Prime preferred stock into common stock $ 1     1
Conversion of Series A-2 Prime preferred stock into common stock (in Shares) 462,245 (2,265)            
Issuance of common stock for cash, net of issuance costs $ 2     14,437 14,439
Issuance of common stock for cash, net of issuance costs (in Shares) 2,155,230              
Unrealized loss on marketable securities, net     7 7
Stock-based compensation expense     2,877 2,877
Balance at Jun. 30, 2026 $ 28     $ 195,635 $ (142,370) $ (23) $ 53,270
Balance (in Shares) at Jun. 30, 2026 27,855,257